30.3 C
Vientiane
Wednesday, July 9, 2025
spot_img
Home Blog Page 288

Smart Digital Group Limited Announces Closing of Initial Public Offering

SINGAPORE, May 6, 2025 /PRNewswire/ – Smart Digital Group Limited (the “Company”) (Nasdaq: SDM), a digital marketing service provider in Singapore, today announced the closing of its initial public offering (the “Offering”) of 1,500,000 ordinary shares, par value $0.001 per share (“Ordinary Shares”), at a public offering price of US$4.00 per share.

The Company received aggregate gross proceeds of US$6.0 million from the Offering, before deducting underwriting discounts and other related expenses. In addition, the Company granted the underwriters a 45-day option to purchase up to an additional 225,000 Ordinary Shares at the public offering price, less underwriting discounts. The Ordinary Shares began trading on the Nasdaq Capital Market on May 2, 2025 under the ticker symbol “SDM.”

Proceeds from the Offering will be used for business expansion, brand promotion and marketing, software development, and for working capital and other general corporate purposes.

The Offering is being conducted on a firm commitment basis. US Tiger Securities, Inc. is acting as the sole book-runner for the Offering. Hunter Taubman Fischer & Li LLC is acting as counsel to the Company, and VCL Law LLP is acting as counsel to the underwriters in connection with the Offering.

A registration statement on Form F-1 relating to the Offering was filed with the Securities and Exchange Commission (the “SEC”) (File Number: 333-283152) and was declared effective by the SEC on May 1, 2025. The Offering is being made only by means of a prospectus, forming a part of the registration statement. Copies of the final prospectus relating to the Offering may be obtained from US Tiger Securities, Inc. by email at ECM@ustigersecurities.com, by calling +1 646-978-5188, or by standard mail to 437 Madison Avenue, 27th Floor, New York, New York 10022. In addition, a copy of the prospectus relating to the Offering may be obtained via the SEC’s website at www.sec.gov.

Before you invest, you should read the prospectus and other documents the Company has filed or will file with the SEC for more complete information about the Company and the Offering. This press release does not constitute an offer to sell, or the solicitation of an offer to buy any of the Company’s securities, nor shall such securities be offered or sold in the United States absent registration or an applicable exemption from registration, nor shall there be any offer, solicitation or sale of any of the Company’s securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction.

About Smart Digital Group Limited

Smart Digital Group Limited is a digital marketing service provider headquartered in Singapore. The Company provides event planning and execution services, internet media services, software customization and marketing services and business planning and consulting services. For more information, visit the Company’s website at http://www.sdmmeta.com/.

Forward-Looking Statements

All statements other than statements of historical fact in this announcement are forward-looking statements, including but not limited to, the Company’s proposed Offering. These forward-looking statements involve known and unknown risks and uncertainties and are based on current expectations and projections about future events and financial trends that the Company believes may affect its financial condition, results of operations, business strategy, and financial needs, including the expectation that the Offering will be successfully completed. Investors can identify these forward-looking statements by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to,” or other similar expressions. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and in its other filings with the SEC.

Global First-in-Class AT2R Antagonist TRD205 Advances to Phase II: First Patient Dosed in Chronic Post-Surgical Neuropathic Pain Trial

BEIJING, May 6, 2025 /PRNewswire/ — Beijing Tide Pharmaceutical Co., Ltd., a subsidiary of Sino Biopharmaceutical Limited (1177.HK), has achieved a milestone in developing its first-in-class analgesic drug (research code: TRD205), a highly selective angiotensin II type 2 receptor (AT2R) antagonist, with the first patient successfully dosed. As the first globally innovative drug targeting chronic post-surgical neuropathic pain (CPSP) to enter Phase II clinical development, TRD205 is positioned to overcome the limitations of existing opioid therapies and provide a safer, more effective solution for hundreds of millions of patients worldwide.

Mechanistic Breakthrough: Pioneering Non-Opioid Analgesic Pathways via AT2R Targeting

CPSP affects approximately 10% of surgical patients globally, translating to over 30 million cases annually. Current treatments face significant constraints: opioids demonstrate efficacy in only 25% of patients while carrying risks of addiction and depression, whereas NSAIDs and antidepressants show limited efficacy against neuropathic pain. TRD205’s core innovation lies in its precise inhibition of AT2R, a receptor whose abnormal activation post-peripheral nerve injury triggers macrophages to release reactive oxygen/nitrogen species. This process exacerbates calcium influx in dorsal root ganglion (DRG) sensory neurons, amplifying pain sensitization. By selectively blocking this pathway, TRD205 suppresses pain signaling at its source without engaging the central nervous system, thereby avoiding opioid-related risks such as addiction and respiratory depression. The drug has secured clinical trial approvals from both the U.S. FDA and China’s NMPA, with Phase I trials in healthy Chinese volunteers confirming favorable safety and pharmacokinetic profiles.

Addressing the Urgent Unmet Need in CPSP: A Public Health Priority

CPSP defined as pain persisting for over three months following surgery, impacts approximately 10% of the 320 million annual surgical patients globally. It is particularly prevalent after procedures such as limb amputation (50%-85%), thoracotomy (30%-50%), breast surgery (25%-50%), and hernia repair (5%-35%), etc. Beyond physical suffering, CPSP is closely linked to anxiety, depression, and other symptoms. Existing therapies address less than 30% of clinical demand, highlighting the critical need for novel mechanisms like TRD205’s opioid-free approach. The Phase II study plans to enroll 184 patients with CPSP to evaluate pain score (NRS) improvements across dose groups over a six-week period.

Market Potential and Strategic Positioning in a $10 Billion Landscape

Global AT2R-targeted drug development remains nascent, with only a few competitors like Lilly-partnered CFTX-1554 (Phase I). TRD205’s approval would make it the first AT2R therapy for CPSP, with expansion potential into indications such as diabetic neuropathy and postherpetic neuralgia—a combined market exceeding $10 billion.

TRD205’s Phase II trial initiation marks a pivotal transition from opioid-dependent analgesia to precision targeting. Successful clinical validation would deliver a novel therapeutic paradigm for over hundreds of millions of patients globally.

Unlocking innovation: Endeavour Energy and mPrest expand partnership to enhance management of community batteries

SYDNEY and TEL AVIV, Israel, May 6, 2025 /PRNewswire/ — Endeavour Energy and mPrest today announced the expansion of their strategic collaboration to deliver a dynamic market-network approach to energy storage and flexibility which enables customers, retailers and networks to work together to maximise the value of local energy resources.

 

 

At the heart of this expanded partnership is the broader deployment of mPrest’s Distributed Energy Resource Management System (mDERMS), which enables real-time monitoring and control of Endeavour Energy’s growing fleet of community batteries.

The mDERMS platform enables real-time optimisation of both network assets and customer-owned technologies such as rooftop solar and batteries, with advanced visibility, forecasting, and control over local demand, generation, and grid constraints – supporting smarter use of locally generated renewables while enhancing power quality, reliability, and energy flow efficiency.

By providing real-time data access to energy retailers and aggregators, the platform creates opportunities for innovative new products that expand customer choice, flexibility, and engagement to enhance participation in broader energy markets, helping to maximise customers’ use of renewable energy and strengthen grid stability.

Endeavour Energy has already deployed mDERMS to oversee its community microgrid and Virtual Power Plant (VPP) in Bawley Point and Kioloa on the NSW South Coast. This next phase will scale those capabilities to support one of New South Wales’ largest community battery initiatives.

In partnership with the Australian Government, Endeavour Energy is deploying the largest community battery program in NSW and is nearing completion in the rollout of 76 community batteries across 33 suburbs to give households access to more affordable, sustainable energy through shared renewable storage.

The integration of MPrest’s mDERMS solution will mark another significant step toward a smarter, more sustainable energy future for Endeavour Energy customers by supporting innovation and creating more flexibility in local energy markets.

Quotes attributable to Endeavour Energy

Endeavour Energy’s General Manager Future Grid and Asset Management, Colin Crisafulli: “Our vision is to lead the transition to smarter, more sustainable energy solutions which provide our customers with greater choices and access to renewable energy options for a more sustainable energy future.In partnership with the Federal Government, we are delivering the largest community battery program in NSW, and this extended partnership with mPrest will further enhance local grid resilience by increasing Customer Energy Resources hosting capacity as well as providing opportunities for retailers and aggregators to desing new products and services for our customers.” 

Quotes attributable to mPrest

mPrest Chief Executive Officer Natan Barak: echoed this sentiment, noting that the development of this critical use case demonstrates the depth of collaboration between both companies. “Now is the time for transformative change in the energy landscape, and we are proud to partner with Endeavour Energy to empower communities for a sustainable energy future,” he said. Additionally, this distinct use case highlights additional mDERMS capabilities, providing support and advantages for utilities, VPPs, retailers, C&I sectors, and customers alike. 

mPrest Chief Commercial Officer Ron Halpern: highlighted the significance of the Australian market, “We are honoured to play a pivotal role in supporting Australia’s leading renewable energy sector through key initiatives such as Endeavour Energy’s microgrid and community battery projects. As the global market evolves, Australia’s advancements in renewable CER/DER and DERMS will serve as a model for others to follow.” 

Media enquiries:
•  Endeavour Energy: 0409 664 608 CorporateComms@endeavourenergy.com.au
•  mPrest: info@mprest.com  

About Endeavour Energy 
Endeavour Energy is one of Australia’s most efficient electricity distribution networks, powering NSW’s fastest growing economies and sustaining the jobs and lifestyles of 2.7 million Australians, living, and working in Central West NSW, The Blue Mountains, Greater Western Sydney, Southern Highlands, Illawarra and South Coast of NSW.

Since 1890, we have expanded our footprint to be at the forefront of Australia’s energy industry in integrating traditional and renewable energy sources to deliver a smarter, cleaner, affordable and more reliable energy system, with clear commitments and pathways to creating sustainable value for customers and communities. Endeavour Energy is committed to decarbonising the grid by 2035. Our mission is to leverage the latest technology and data to plan the grid of tomorrow where batteries, microgrids and solar integrate seamlessly with the traditional distribution network to power communities for a brighter future.

About mPrest 
Leveraging its unparalleled experience and expertise in real-time mission-critical command and control software, mPrest has developed the world-leading distributed asset orchestration and optimization software. mPrest’s micro-services based, real-time orchestration and optimization platform brings the power of AI and IoT to the digital transformation of the energy and other industrial IOT markets. mPrest’s applications suite, including Distributed Energy Resources Management Systems (DERMS) and Asset Health Management (AHM) are deployed on premise or in the cloud in record time in the most forward-looking and efficient organizations worldwide, including some of the world’s largest energy companies. mPrest’s vendor-agnostic product suite interfaces with millions of sensors, devices, machines, assets, subsystems, IT and OT applications, creating a system of systems that provides end-to-end visibility and control over complex and distributed operations. Visit us at www.mprest.com.

Trimble Announces Dimensions Australia, Expanding Access to Flagship User Conference Experience

Event Highlights Innovation in Connected Construction and Geospatial Technology in the Asia-Pacific Region

Registration is Now Open

WESTMINSTER, Colo., May 6, 2025 /PRNewswire/ — Trimble (Nasdaq: TRMB) is excited to announce Trimble Dimensions Australia, a new regional user conference taking place August 27-28 in Brisbane, Australia. Tailored for engineering and construction professionals, the conference provides two days of fast-paced education on innovative technology solutions, and dedicated opportunities to connect with peers and product experts.

Trimble Announces Dimensions Australia, Expanding Access to Flagship User Conference Experience
Trimble Announces Dimensions Australia, Expanding Access to Flagship User Conference Experience

Trimble’s renowned Dimensions Offsite Expo will be a key feature of the event, showcasing the latest machine control, monitoring, mapping and positioning technologies in live action as well as numerous hands-on learning opportunities.

In addition, attendees will be able to explore the convergence of the physical and digital worlds through:

  • Understanding the Impact of Artificial Intelligence (AI) technologies on the engineering and construction industry.
  • 50+ Educational Sessions to gain practical insights and learn from industry leaders.
  • Hands-on Technology Labs to experience the latest technology innovations and learn how to unlock maximum value from Trimble solutions.
  • A Unique Scanning Experience Center to discover the power of 3D scanning and reality capture.

Keynote: Future of Connected Construction
Trimble executives will kick off Dimensions Australia with a compelling keynote, showcasing the latest Trimble innovations and their impact on the construction project lifecycle. Through real-world examples, Trimble executives will demonstrate how connected data and emerging technologies are driving collaboration, productivity, efficiency and sustainability.

Join Us in Australia
Registration is open. The Star Brisbane Hotel will serve as the hub for this one-of-a-kind event, bringing hundreds of construction and engineering professionals together. Don’t miss this opportunity to:

  • Connect: Network with industry peers and Trimble experts.
  • Discover: Explore the latest technology advancements from Trimble.
  • Innovate: Gain the tools to solve today’s challenges and shape tomorrow’s industry.

For more information and to register, please visit: https://www.trimble.com/en/our-company/events/dimensions-australia/overview

About Trimble
Trimble is a global technology company that connects the physical and digital worlds, transforming the ways work gets done. With relentless innovation in precise positioning, modeling and data analytics, Trimble enables essential industries including construction, geospatial and transportation. Whether it’s helping customers build and maintain infrastructure, design and construct buildings, optimize global supply chains or map the world, Trimble is at the forefront, driving productivity and progress. For more information about Trimble (Nasdaq: TRMB), visit: www.trimble.com.

GTRMB

 

INTREPID Alliance Releases New Report Highlighting Urgent Gaps in Antiviral Preparedness

Global antiviral R&D is slowing when the world can least afford it,  new analysis shows

CAMBRIDGE, Mass., May 6, 2025 /PRNewswire/ — The INTREPID Alliance today released the fourth edition of its Antiviral Clinical and Preclinical Development Landscape, a comprehensive analysis of the global pipeline of small-molecule antiviral compounds. The findings reveal a concerning trend: rather than accelerating in response to global preparedness goals, antiviral R&D momentum is stalling. Drawing on data from over 200 clinical and preclinical antiviral programs across 13 viral families prioritized for pandemic preparedness, the report provides a timely snapshot of where progress is being made – and where gaps remain.

The landscape still shows that the majority of clinical and preclinical compounds under investigation are targeting the viruses where infection can lead to outbreaks of COVID-19 and influenza. Other indications where limited clinical and/or preclinical development work is underway include Mpox, Dengue, Ebola, and Lassa fever, among others. However, there are several viral families of pandemic potential with no compounds in clinical or preclinical development at this time leaving the world at risk of future outbreaks.

“We are going backwards, not forwards,” said James Anderson, Executive Director of Global Health at the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) and Chair of the INTREPID Alliance Board. “Despite the lessons of COVID-19, global investment in small-molecule antivirals is declining just when we need to be scaling up. Without a robust antiviral pipeline, the world remains dangerously exposed to emerging viral threats. This landscape is both a wake-up call and a roadmap for smarter, faster preparedness.”

Key Findings from the 4th Edition Landscape: *

  • Clinical pipeline: 67 distinct antiviral compounds are currently in active clinical development, with 22 approved compounds and 42 of those being novel, unapproved candidates. However, the overall number of promising new clinical candidates has not increased since the previous edition, highlighting a plateau in progress.
  • Preclinical pipeline: 168 novel compounds are in preclinical development, associated with 189 virus-disease indications. Yet the majority of these still target SARS-CoV-2, leaving many pandemic-priority viral families under-addressed.
  • R&D concentration: While nearly 90% of clinical development activity is being led by biopharmaceutical companies, early-stage research is more diverse, with contributions from academia and government labs. Still, most programs are concentrated in high-income countries, underscoring the need for more widespread global engagement.

The recent outbreaks of Mpox disease, which sparked the World Health Organization to declare public health emergencies of international concern,1,2 should be a wake-up call to the international community that the world is not immune to emerging and future outbreaks. The INTREPID Alliance Report on Direct-Acting Antivirals for Mpox, published last month highlights the urgent need for increased research and development of antiviral treatments for monkey pox virus and other orthopoxviruses with pandemic potential.

“In our interconnected world, a strong antiviral pipeline is not just a scientific issue – it’s a global security issue,” said Kelly Chibale, Ph.D., Professor, Neville Isdell Chair in African-centric Drug Discovery and Development, University of Cape Town. “We need to make sure innovation is not only happening but also reaching the places most vulnerable to future outbreaks. The INTREPID Landscape is a critical tool for making smarter, more informed decisions.” As a member of its Scientific Advisory Board, Professor Chibale is one of the scientific experts from around the world who advises INTREPID’s work.

INTREPID’s bi-annual antiviral pipeline reports are a key contribution to the 100 Days Mission, whose aim is to be prepared as much as possible so that within the first 100 days of a new pandemic threat being identified, interventions can be made available, safe, effective, and affordable. INTREPID’s research is freely available and is intended to support policymakers, funders, and the global scientific community in identifying the most urgent needs and highest-impact opportunities in antiviral R&D.

The full landscape report, study methodology, and an interactive antiviral clinical development pipeline are available at the INTREPID website. The INTREPID Alliance deep dive report focused on direct-acting antivirals for Mpox is also available through the website’s Deep Dive Reports section.

Disclaimer

The INTREPID Alliance is a non-profit consortium of innovative biopharmaceutical companies and associations committed to accelerating the development of antivirals for epidemic and pandemic threats. Through independent landscape analysis and policy engagement, the Alliance supports science-based investment and preparedness strategies aligned with global public health goals. 

As part of our efforts, the INTREPID Alliance maintains and publishes a centralized list of promising investigational candidate compounds, with the purpose of knowledge-sharing and to support better pandemic preparedness. These compounds have been selected based on objective, scientific criteria, using publicly available sources, and at arm’s length from commercial influence of our member companies. See criteria listed in the report “Antiviral Clinical Development Landscape and Promising Clinical Compounds.” The designation of certain compounds as promising is based upon currently available information, and exclusively upon an assessment against these criteria. “Promising” is not a promotional claim. Candidate compounds have not been assessed by regulatory authorities to be safe and efficacious for the treatment of disease in humans. Our content is designed to be factual, informative, and non-commercial. It is not designed or intended to advertise or promote any pharmaceutical product or therapy or to advance the commercial interests of any company.

ABOUT THE INTREPID ALLIANCE

The INTREPID Alliance aims to accelerate the development of new treatments for emerging viral pandemic agents through facilitating early science and R&D, policy and advocacy, and stakeholder engagement. Led by a not-for-profit consortium of innovative biopharmaceutical companies and associations and working with the public, private and not-for-profit sectors, INTREPID works to bridge key gaps and unmet needs to ensure delivery of antiviral solutions to viral pathogens with the greatest pandemic potential.

INTREPID was launched in March 2023 at a high-level summit bringing together more than 100 thought leaders in virology and global health. For a read-out from the summit and additional information, visit www.intrepidalliance.org.

* As of December 18, 2024

1 World Health Organization (WHO). WHO Director-General declares the ongoing monkeypox outbreak a Public Health Emergency of International Concern. (23 July 2022).
2 World Health Organization (WHO). WHO Director-General declares mpox outbreak a public health emergency of international concern. (14 August 2024).

 

YäRKEN Raises Funds from 1982 Ventures to Expand AI-Driven IT Financial Management Across North American Enterprise Clients

NEW YORK, May 6, 2025 /PRNewswire/ — YäRKEN, the first AI native IT Financial Management (ITFM) platform for enterprise clients has announced a fundraising round led by 1982 Ventures. This funding will enable YäRKEN to further develop its AI capabilities and scale its customer base across North America.

The ITFM market is projected to grow at 12.7% per annum and hit US$14 billion (according to Business Research Insights, forecast period 2025-2033). This growth is driven by CIOs’ increasing need for solutions to effectively manage and forecast complex cloud and on-premises investments as well as managing software licences and usage across multiple business units. Yarken’s AI-native approach reduces implementation times, delivers average cost reductions of 15-25%, and significantly reduces ongoing maintenance hours by up to 50%.

Yarken was founded by seasoned entrepreneurs Ravi Kuppan (CEO) and Vaibhav Kulkarni (CTO), after the successful sale of their enterprise software company Tarantula Global to Constellation Software. Kuppan said, “Our years delivering software to large global enterprises showed us CIOs are struggling to manage sprawling IT infrastructure costs with legacy solutions and spreadsheets that are inflexible, slow to deploy, and expensive to maintain. We knew how to solve this by leveraging AI.”

Ravi Kuppan, Yarken CEO stated, “Yarken’s native AI can ingest and analyze data from any IT system, regardless of format. This means whether you’re tracking cloud spending, software licenses, or hardware assets, our clients gain comprehensive, actionable cost insights months faster than our competitors.” He added, “Yarken’s platform provides comprehensive audit trails and cost transparency, helping enterprises maintain compliance and enhance IT governance.”

Yarken, which was recently included in Gartner’s 2025 Market Guide for ITFM as an established offering, has been rapidly expanding in the United States and Canada.  US based Maryville Consulting, recognized for its expertise in Technology Business Management, will now offer Yarken’s platform to its extensive portfolio of enterprise clients, giving them streamlined access to Yarken’s powerful analytics and cost management tools.

“Yarken’s light TBM approach and ease of use help us provide innovative solutions to the North American market. By integrating Yarken’s platform into our service offerings, we can help clients gain deeper insights into IT spend and drive more strategic decision-making.” said Quinn Abraham, VP of TBM / FinOps at Maryville Consulting.

“Many CIOs are faced with the competing mandates of reducing costs while continuing to invest in new systems. Yarken’s AI-native platform gives CIOs full visibility on their tech spend, with integrated forecasting and benchmarking that produce actionable insights, including rapid IT planning capabilities, allowing for proactive budget adjustments that the business can collaborate on. The solution pays for itself,” said James Kim, Operating Partner of 1982 Ventures and former Managing Director at Accenture. He added, “Yarken is the only platform that integrates all areas of IT financial management and cloud operations with native AI, allowing enterprise clients to achieve faster time to value.”

Scott Krivokopich, Founding Managing Partner at 1982 Ventures, stated, “We are excited to support founders like Ravi and Vaibhav, who have a proven track record of building and exiting successful enterprise software companies. Our investment in Yarken fits perfectly within our strategy of backing companies that are leveraging AI to transform financial services and enterprise operations. Yarken’s innovative approach to IT financial management, powered by native AI, is precisely the kind of disruption we believe will reshape the industry.”

The funding will fuel Yarken’s next phase of growth. Specifically, the company plans to aggressively expand its customer base across North America, further develop its AI capabilities and scale operational capacity to support this growth. Building on the success of global SI partnerships.  Yarken is also exploring more strategic partners with key industry players to broaden its market reach and further enhance its service offerings.

Kuppan added, “We’re just getting started.  This investment enables us to deliver even more value to our customers and partners as we redefine how enterprises manage IT spend.”

About Yarken:

YäRKEN is a leading AI-native IT Financial Management (ITFM) solution provider recognized for its innovative approach and featured in Gartner’s Market Guide for ITFM 2025. Yarken enables businesses to gain complete visibility into their IT spend, optimize costs, and make strategic decisions through AI-driven insights, forecasting, and benchmarking. Yarken’s platform simplifies ITFM, providing faster implementation, enterprise-grade scalability, and robust analytics.

For more information, visit: www.yarken.com 

RuggON Showcases AI-Driven Rugged Fleet Solutions at WasteExpo 2025, Empowering Smarter & Greener Waste Management

LAS VEGAS, May 5, 2025 /PRNewswire/ — RuggON, a subsidiary of Ubiqconn Technology and a leading provider of rugged mobile computing solutions, is proud to announce its participation at WasteExpo 2025, North America’s premier waste and recycling event. At Booth #879, RuggON will unveil its next-generation AI-powered vehicle mount computers and fleet solutions tailored for waste management operators seeking to digitize, optimize, and decarbonize their operations.

RuggON Showcases AI-Driven Rugged Fleet Solutions at WasteExpo 2025, Empowering Smarter & Greener Waste Management
RuggON Showcases AI-Driven Rugged Fleet Solutions at WasteExpo 2025, Empowering Smarter & Greener Waste Management

Amid growing global demand for sustainability in urban infrastructure, RuggON’s ruggedized solutions provide waste fleets with real-time vehicle diagnostics, intelligent route planning, and proactive maintenance capabilities. Through seamless integration with CAN bus and SAE J1939 standards, these vehicle mount computers enable instant access to operational data and AI-assisted safety alerts, such as blind spot detection and driver monitoring — reducing risks on the road and boosting driver accountability.

Built for the toughest environments, RuggON’s vehicle-mounted platforms meet military-grade standards for shock and vibration resistance, ensuring performance in the most demanding waste collection conditions. With LEOs, 5G, 4G/LTE, and WiFi connectivity onboard, waste fleet operators can transmit and receive critical data across systems with speed and reliability, facilitating decisions that reduce downtime, lower emissions, and extend vehicle life cycles.

“We’re excited to demonstrate how our rugged solutions empower the waste industry to embrace digital transformation while staying aligned with sustainability goals,” said Tim Tsai, North America CEO of Ubiqconn. “Our technologies are not just built for durability — they’re built for a cleaner future.”

RuggON is proud to be driving innovation in waste management. By empowering frontline operators with reliable, AI-powered solutions, we’re not just supporting cleaner cities—we’re helping build a smarter, more sustainable future.

About RuggON

RuggON Corp., a subsidiary of Ubiqconn Technology, is a leading manufacturer of rugged mobile computing solutions. Combining Ubiqconn’s advanced technology to drive innovation and expand in the Mobile Industrial (IioT) market, RuggON leverages decades of expertise to improve mobile productivity in harsh environments. A committed engineering team delivers devices of exceptional value and quality that enhance user experience. The company understands the diverse demands of industries to provide tailored, efficient solutions. RuggON is dedicated to higher standards for customer satisfaction and prides itself on offering endless possibilities to meet tomorrow’s needs. For more information, visit http://www.ruggon.com or follow us on LinkedIn

Zindi Supports Cassava Technologies with 85 K Zindians to showcase African AI innovation


DUBAI, UAE – Media OutReach Newswire – 5 May 2025 – Zindi, the leading professional network for data scientists and AI developers in emerging markets, is pleased to announce that it has signed a Memorandum of Understanding (MOU) with Cassava Technologies, a global technology leader of African heritage, to deliver artificial intelligence (AI) solutions and GPU-as-a-Service (GPUaas) across the African continent.

This partnership represents a significant step in accelerating digital transformation in Africa and will see the two organisations collaborate on several initiatives. These include using Cassava’s GPUaaS capabilities for Zindi’s AI solution development and identifying opportunities for both organisations to leverage one another’s platforms and ecosystems.

As Africa’s pioneering data science competition platform, Zindi collaborates with companies, non-profit organisations, and government institutions to develop, curate, and prepare data-driven challenges. This partnership underscores their mutual commitment to nurturing AI talent and innovation throughout the continent.

Zindi CEO and Co-Founder, Celina Lee states:

“Zindi is thrilled at the opportunity to partner with Cassava Technologies to strengthen African datasets and address local problems with locally developed solutions. Using Cassava’s GPU capabilities, which are essential for handling the large and complex computations that AI and machine learning models require, and collaborating on the launch of a competition specifically aimed at nurturing Africa’s AI talent will not only expose entrepreneurs and innovative solutions; it will help build new skills and create employment opportunities,”

With the signing of this MOU, Cassava and Zindi are set to make significant inroads in Africa’s AI landscape. The partnership supports Cassava’s objective of providing world-class digital solutions and advancing responsible AI adoption, innovation, and growth in Africa. This follows its recent announcement of its plans to build Africa’s first AI factory and the 2024 launch of Cassava’s AI business.

Hashtag: #Zindi

The issuer is solely responsible for the content of this announcement.

About Zindi

Zindi is also present in the Caribbean. Join Saturday May 10th 2025 Barbados hackathon

Zindi is the first uniquely African data science competition platform. Zindi hosts an entire data science ecosystem of scientists, engineers, academics, companies, NGOs, governments and institutions focused on solving Africa’s most pressing problems. Zindi works with companies, non-profit organizations, and government institutions to develop, curate, and prepare data-driven challenges. Solutions are ranked automatically by the accuracy achieved. Whether you are testing the data science waters for the first time or trying to crack a persistent business problem with data, Zindi helps organizations push their creative boundaries at an affordable cost. For data scientists, from newbies to rock stars, Zindi is a place to access African datasets and solve African problems. Data scientists will find all the tools they need on Zindi to compete, share ideas, hone their skills, build their professional profiles, find career opportunities, and have fun!